Ascendis Pharma (ASND) reported its fourth-quarter 2024 earnings, highlighting a significant revenue increase and a positive market reaction. The company posted total revenue of €173.9 million for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback